| 臺大學術典藏 |
2021-09-27T05:32:39Z |
Antimicrobial susceptibility of bacteremic vancomycin-resistant Enterococcus faecium to eravacycline, omadacycline, lipoglycopeptides, and other comparator antibiotics: Results from the 2019–2020 Nationwide Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)
|
Tsai H.-Y.; Lee Y.-L.; Liu P.-Y.; Lu M.-C.; Shao P.-L.; Lu P.-L.; Cheng S.-H.; Ko W.-C.; Lin C.-Y.; Wu T.-S.; Yen M.-Y.; Wang L.-S.; Liu C.-P.; Lee W.-S.; Shi Z.-Y.; Chen Y.-S.; Wang F.-D.; Tseng S.-H.; Chen Y.-H.; WANG-HUEI SHENG; Lee C.-M.; Chen Y.-H.; Liao C.-H.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-09-27T05:32:37Z |
In-vitro activity of cefiderocol, cefepime/zidebactam, cefepime/enmetazobactam, omadacycline, eravacycline and other comparative agents against carbapenem-nonsusceptible Enterobacterales: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2017–2020
|
Lee Y.-L.; Ko W.-C.; Lee W.-S.; Lu P.-L.; Chen Y.-H.; Cheng S.-H.; Lu M.-C.; Lin C.-Y.; Wu T.-S.; Yen M.-Y.; Wang L.-S.; Liu C.-P.; Shao P.-L.; Shi Z.-Y.; Chen Y.-S.; Wang F.-D.; Tseng S.-H.; Lin C.-N.; Chen Y.-H.; WANG-HUEI SHENG; Lee C.-M.; Tang H.-J.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-09-27T05:32:37Z |
National surveillance of antimicrobial susceptibilities to dalbavancin, telavancin, tedizolid, eravacycline, omadacycline and other comparator antibiotics and serotype distribution of invasive Streptococcus pneumoniae isolates in adults: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) programme in 2017–2020
|
Chien Y.-C.; Lee Y.-L.; Liu P.-Y.; Lu M.-C.; Shao P.-L.; Lu P.-L.; Cheng S.-H.; Lin C.-Y.; Wu T.-S.; Yen M.-Y.; Wang L.-S.; Liu C.-P.; Lee W.-S.; Shi Z.-Y.; Chen Y.-S.; Wang F.-D.; Tseng S.-H.; Chen Y.-H.; WANG-HUEI SHENG; Lee C.-M.; Chen Y.-H.; Ko W.-C.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-09-17T05:41:24Z |
Augmented fluoroscopic bronchoscopy (AFB) versus percutaneous computed tomography-guided dye localization for thoracoscopic resection of small lung nodules: a propensity-matched study
|
Yang S.-M.; Chen Y.-C.; Ko W.-C.; Huang H.-C.; KAI-LUN YU; Ko H.-J.; Huang P.-M.; Chang Y.-C. |
| 臺大學術典藏 |
2021-09-17T05:40:30Z |
Gender difference in clinical and genetic characteristics of Brugada syndrome: SADS-TW BrS registry
|
Chen C.-Y.J.; Juang J.-M.J.; Lin L.-Y.; Liu Y.-B.; Ho L.-T.; Yu C.-C.; Huang H.-C.; Lin T.-T.; Liao M.-C.; Chen J.-J.; Hwang J.-J.; Chen W.-J.; Yeh S.-F.S.; Yang D.-H.; Chiang F.-T.; Lin J.-L.; Lai L.-P.; Horie M.; Wu M.-H.; Wu T.-J.; Chen S.-A.; Wang C.-C.; Chang K.-C.; Feng A.-N.; Lin Y.-J.; Ueng K.-C.; Tsao H.-M.; Huang J.-L.; Tsai W.-C.; Tsai C.-F.; Chang S.-L.; Lo L.-W.; Hu Y.-F.; Chung F.-P.; Chang C.-J.; Lo H.-M.; Chiang M.-C.; Hsia C.-P.; Liu J.-F.; SHUENN-NAN CHIU; Lin M.-T.; Chua S.-K.; Hsieh Y.-C.; Li C.-H.; Liao Y.-C.; Lin H.-H.; Liu Z.-Z.; Ye G.-H.; Chiu W.-R.; Chang J.-R.; Feng W.-J.; Chang S.-X.; Lei M.-H.; Ko W.-C.; Kong C.-W.; Kuo C.-T.; Huang B.-X.; Li K.-T.; Chen W.-D.; Luo J.-L.; Lin J.-Y.; Tsai T.-N.; Hsu C.-T.; Lin L.-R.; Chen R.-Y.; Li P.-T.; Stephen Huang S.K.; SADS-TW BrS Registry |
| 臺大學術典藏 |
2021-09-14T02:45:52Z |
Multicenter evaluation of two chemiluminescence and three lateral flow immunoassays for the diagnosis of COVID-19 and assessment of antibody dynamic responses to SARS-CoV-2 in Taiwan
|
Chen S.-Y.; Lee Y.-L.; Lin Y.-C.; Lee N.-Y.; Liao C.-H.; Hung Y.-P.; Lu M.-C.; JHONG-LIN WU; Tseng W.-P.; Lin C.-H.; Chung M.-Y.; Kang C.-M.; Lee Y.-F.; Lee T.-F.; Cheng C.-Y.; Chen C.-P.; Huang C.-H.; Liu C.-E.; Cheng S.-H.; Ko W.-C.; Hsueh P.-R.; Chen S.-C. |
| 臺大學術典藏 |
2021-09-09T07:52:41Z |
Gender difference in clinical and genetic characteristics of Brugada syndrome: SADS-TW BrS registry
|
Chen C.-Y.J.; Juang J.-M.J.; Lin L.-Y.; Liu Y.-B.; Ho L.-T.; CHIH-CHIEH YU; Huang H.-C.; Lin T.-T.; Liao M.-C.; Chen J.-J.; Hwang J.-J.; Chen W.-J.; Yeh S.-F.S.; Yang D.-H.; Chiang F.-T.; Lin J.-L.; Lai L.-P.; Horie M.; Wu M.-H.; Wu T.-J.; Chen S.-A.; Wang C.-C.; Chang K.-C.; Feng A.-N.; Lin Y.-J.; Ueng K.-C.; Tsao H.-M.; Huang J.-L.; Tsai W.-C.; Tsai C.-F.; Chang S.-L.; Lo L.-W.; Hu Y.-F.; Chung F.-P.; Chang C.-J.; Lo H.-M.; Chiang M.-C.; Hsia C.-P.; Liu J.-F.; Chiu S.-N.; Lin M.-T.; Chua S.-K.; Hsieh Y.-C.; Li C.-H.; Liao Y.-C.; Lin H.-H.; Liu Z.-Z.; Ye G.-H.; Chiu W.-R.; Chang J.-R.; Feng W.-J.; Chang S.-X.; Lei M.-H.; Ko W.-C.; Kong C.-W.; Kuo C.-T.; Huang B.-X.; Li K.-T.; Chen W.-D.; Luo J.-L.; Lin J.-Y.; Tsai T.-N.; Hsu C.-T.; Lin L.-R.; Chen R.-Y.; Li P.-T.; Stephen Huang S.K.; SADS-TW BrS Registry |
| 臺大學術典藏 |
2021-08-27T06:48:54Z |
Evolution of hepatitis A virus seroprevalence among HIV-positive adults in Taiwan
|
Lee Y.-L.; KUAN-YIN LIN; Cheng C.-Y.; Li C.-W.; Yang C.-J.; Tsai M.-S.; Tang H.-J.; Lin T.-Y.; Wang N.-C.; Lee Y.-C.; Lin S.-P.; Huang Y.-S.; Sun H.-Y.; Zhang J.-Y.; Ko W.-C.; Cheng S.-H.; Lee Y.-T.; Liu C.-E.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-27T06:48:54Z |
Trends and outcomes of late initiation of combination antiretroviral therapy driven by late presentation among HIV-positive Taiwanese patients in the era of treatment scale-up
|
KUAN-YIN LIN; Cheng C.-Y.; Li C.-W.; Yang C.-J.; Tsai M.-S.; Liu C.-E.; Lee Y.-T.; Tang H.-J.; Wang N.-C.; Lin T.-Y.; Lee Y.-C.; Lin S.-P.; Huang Y.-S.; Zhang J.-Y.; Ko W.-C.; Cheng S.-H.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-27T06:48:47Z |
Hepatitis B virus seroprevalence among HIV-infected patients receiving combination antiretroviral therapy three decades after universal neonatal hepatitis B immunization program in Taiwan
|
Lin J.-J.; KUAN-YIN LIN; Tang H.-J.; Lin S.-P.; Lee Y.-C.; Liu C.-E.; Huang Y.-S.; Wang N.-C.; Li C.-W.; Ko W.-C.; Yang H.-J.; Lee Y.-T.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-25T01:53:13Z |
Evolution of hepatitis A virus seroprevalence among HIV-positive adults in Taiwan
|
Lee Y.-L.; KUAN-YIN LIN; Cheng C.-Y.; Li C.-W.; Yang C.-J.; Tsai M.-S.; Tang H.-J.; Lin T.-Y.; Wang N.-C.; Lee Y.-C.; Lin S.-P.; Huang Y.-S.; Sun H.-Y.; Zhang J.-Y.; Ko W.-C.; Cheng S.-H.; Lee Y.-T.; Liu C.-E.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-25T01:53:13Z |
Trends and outcomes of late initiation of combination antiretroviral therapy driven by late presentation among HIV-positive Taiwanese patients in the era of treatment scale-up
|
KUAN-YIN LIN; Cheng C.-Y.; Li C.-W.; Yang C.-J.; Tsai M.-S.; Liu C.-E.; Lee Y.-T.; Tang H.-J.; Wang N.-C.; Lin T.-Y.; Lee Y.-C.; Lin S.-P.; Huang Y.-S.; Zhang J.-Y.; Ko W.-C.; Cheng S.-H.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-25T01:53:03Z |
Hepatitis B virus seroprevalence among HIV-infected patients receiving combination antiretroviral therapy three decades after universal neonatal hepatitis B immunization program in Taiwan
|
Lin J.-J.; KUAN-YIN LIN; Tang H.-J.; Lin S.-P.; Lee Y.-C.; Liu C.-E.; Huang Y.-S.; Wang N.-C.; Li C.-W.; Ko W.-C.; Yang H.-J.; Lee Y.-T.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-24T08:23:35Z |
Trends and outcomes of late initiation of combination antiretroviral therapy driven by late presentation among HIV-positive Taiwanese patients in the era of treatment scale-up
|
Lin K.-Y.; Cheng C.-Y.; Li C.-W.; Yang C.-J.; Tsai M.-S.; Liu C.-E.; Lee Y.-T.; Tang H.-J.; Wang N.-C.; Lin T.-Y.; Lee Y.-C.; Lin S.-P.; YU-SHAN HUANG; Zhang J.-Y.; Ko W.-C.; Cheng S.-H.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-24T08:23:34Z |
Changing seroprevalence of hepatitis C virus infection among HIV-positive patients in Taiwan
|
Li C.-W.; Yang C.-J.; Sun H.-Y.; Tsai M.-S.; Lin S.-P.; Lin T.-Y.; Cheng C.-Y.; Lee Y.-C.; YU-SHAN HUANG; Liu C.-E.; Lee Y.-T.; Tang H.-J.; Wang N.-C.; Cheng S.-H.; Ko W.-C.; Hung C.-C. |
| 臺大學術典藏 |
2021-08-24T08:23:34Z |
Evolution of hepatitis A virus seroprevalence among HIV-positive adults in Taiwan
|
Lee Y.-L.; Lin K.-Y.; Cheng C.-Y.; Li C.-W.; Yang C.-J.; Tsai M.-S.; Tang H.-J.; Lin T.-Y.; Wang N.-C.; Lee Y.-C.; Lin S.-P.; YU-SHAN HUANG; Sun H.-Y.; Zhang J.-Y.; Ko W.-C.; Cheng S.-H.; Lee Y.-T.; Liu C.-E.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-24T08:23:34Z |
Treatment of Pneumocystis jirovecii pneumonia in HIV-infected patients: a review
|
YU-SHAN HUANG; Yang J.-J.; Lee N.-Y.; Chen G.-J.; Ko W.-C.; Sun H.-Y.; Hung C.-C. |
| 臺大學術典藏 |
2021-08-24T08:23:33Z |
Less severe but prolonged course of acute hepatitis a in Human Immunodeficiency Virus (HIV)-infected patients compared with HIV-uninfected patients during an outbreak: A multicenter observational study
|
Lee Y.-L.; Chen G.-J.; Chen N.-Y.; Liou B.-H.; Wang N.-C.; Lee Y.-T.; Yang C.-J.; YU-SHAN HUANG; Tang H.-J.; Huang S.-S.; Lin Y.-C.; Cheng C.-Y.; Lee C.-H.; Chen T.-C.; Wu T.-S.; Liu C.-E.; Lu P.-L.; Hung C.-C.; Lee Y.-C.; Cheng C.-Y.; Cheng S.-H.; YU-SHAN HUANG; Lee Y.-T.; Lin C.-C.; Lin S.-P.; Hsieh C.-Y.; Wang H.-W.; Ho M.-W.; Liu C.-E.; Lee Y.-L.; Lee Y.-C.; Tang H.-J.; Ku H.-C.; Li C.-W.; Lee N.-Y.; Ko W.-C.; Lu P.-L.; Chen Y.-H.; Lin H.-H.; Huang W.-C.; Lee C.-H.; Che T.-C. |
| 臺大學術典藏 |
2021-08-24T08:23:28Z |
Hepatitis B virus seroprevalence among HIV-infected patients receiving combination antiretroviral therapy three decades after universal neonatal hepatitis B immunization program in Taiwan
|
Lin J.-J.; Lin K.-Y.; Tang H.-J.; Lin S.-P.; Lee Y.-C.; Liu C.-E.; YU-SHAN HUANG; Wang N.-C.; Li C.-W.; Ko W.-C.; Yang H.-J.; Lee Y.-T.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-24T06:05:06Z |
Fusidic acid for the treatment of bone and joint infections caused by meticillin-resistant Staphylococcus aureus
|
Wang J.-L.; Tang H.-J.; Hsieh P.-H.; Chiu F.-Y.; Chen Y.-H.; Chang M.-C.; Huang C.-T.; Liu C.-P.; Lau Y.-J.; Hwang K.-P.; Ko W.-C.; CHEN-TI WANG; Liu C.-Y.; Liu C.-L.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-08-20T07:10:55Z |
Real-World Experience with Coformulated Ledipasvir and Sofosbuvir for HIV-Positive Patients with HCV Genotype 2 Infection: A Multicenter, Retrospective Study
|
Liou B.-H.; HSIN-YUN SUN; Yang C.-J.; Syue L.-S.; Lee Y.-L.; Tang H.-J.; Tsai H.-C.; Lin C.-Y.; Chen T.-C.; Lee C.-Y.; Huang S.-H.; Liu C.-W.; Lu P.-L.; Lin S.-P.; Wang N.-C.; Cheng A.; Ko W.-C.; Cheng S.-H.; Hung C.-C.; the Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-16T08:36:11Z |
Real-World Experience with Coformulated Ledipasvir and Sofosbuvir for HIV-Positive Patients with HCV Genotype 2 Infection: A Multicenter, Retrospective Study
|
Liou B.-H.; Sun H.-Y.; Yang C.-J.; Syue L.-S.; Lee Y.-L.; Tang H.-J.; Tsai H.-C.; Lin C.-Y.; Chen T.-C.; Lee C.-Y.; Huang S.-H.; Liu C.-W.; Lu P.-L.; Lin S.-P.; Wang N.-C.; ARISTINE CHENG; Ko W.-C.; Cheng S.-H.; Hung C.-C.; the Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-06-22T02:01:46Z |
Evaluation of using high-pressure homogenization technology in enhancing the aroma synthesis of sorghum spirits
|
Chang, C.-K.;Ko, W.-C.;Chen, Y.-A.;Chan, Y.-J.;Cheng, K.-C.;Lai, P.-S.;Hsieh, C.-W.; Chang, C.-K.; Ko, W.-C.; Chen, Y.-A.; Chan, Y.-J.; Cheng, K.-C.; Lai, P.-S.; Hsieh, C.-W.; KUAN-CHEN CHENG |
| 臺大學術典藏 |
2021-05-31T07:03:36Z |
Interaction of thrombin-activated platelets with extracellular matrices (fibronectin and vitronectin): Comparison of the activity of Arg-Gly-Asp-containing venom peptides and monoclonal antibodies against glycoprotein IIb/IIIa complex
|
Sheu J.R.; Ko W.C.; Hung W.C.; Peng H.C.; TUR-FU HUANG |
| 臺大學術典藏 |
2021-05-31T07:03:33Z |
Triflavin potentiates the antiplatelet activity of platelet activating factor receptor antagonist on activated neutrophil-induced platelet aggregation
|
Lee L.-W.; Peng H.-C.; Ko W.-C.; Hung W.-C.; Su C.-H.; Lin C.-H.; TUR-FU HUANG; Yen M.-H.; Sheu J.-R. |
